Clusterin expression and apoptosis in tissue remodeling associated with renal regeneration

Kidney International

Volumn 47, Issue 2, 1995, Pages 411-420

  Gobé, Glenda C ^a   Buttyan, Ralph ^b   Wyburn, Kate R L ^b   Etheridge, Maria R ^b   Smith, Peter J ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATROPHY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGENERATION; TISSUE REGENERATION;

EID: 0028952951     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1995.54     Document Type: Article

References (44)

1. BUTTYAN R, OLSSON CA, PINTAR J, CHANG C, BANDYK M, NG P-Y, SAWCZUK IS: Induction of the TRPM-2 gene in cells undergoing programmed death. Molec Cell Biol 9:3473-3481, 1989
2. SAWCZUK IS, HOKE G, OLSSON CA, CONNOR J, BUTTYAN R: Gene expression in response to acute unilateral ureteral obstruction. Kidney Int 35:1315-1319, 1989
3. CONNOR J, BUTTYAN R, OLSSON C, D'AGATI V, O'TOOLE K, SAWCZUK I: SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis. Kidney Int 39:1098-1103, 1991
4. HARDING MA, CHADWICK LJ, GATTONE VH, CALVET JP: The SGP-2 gene is developmentally regulated in the mouse kidney and abnormally expressed in collecting ducts in polycystic kidney disease. Devel Biol 146:438-490, 1991
5. ROSENBERG ME, PALLER MS: Differential gene expression in recovery from ischemic renal injury. Kidney Int 39:1156-1161, 1991
6. CORREA-ROTTER R, HOSTETTER TH, MANIVEL JC, EDDY AA. ROSENBERG ME: Intrarenal distribution of clusterin following reduction of renal mass. Kidney Int 41:938-950, 1992
7. CORREA-ROTTER R, HOSTETTER TH, NATH KA, MANIVEL JC, ROSENBERG ME: Interaction of complement and clusterin in renal injury. J Am Soc Nephrol 3:1172-1179, 1992
8. SCHLEGEL PN, MATTHEWS GJ, CICHON Z, AULITZKY W, CHENG CY, CHEN CC, SASO L, GOLDSTEIN M, JANNE OA, BARDIN CW, VAUGHAN ED: Clusterin production in the obstructed rabbit kidney: Correlations with loss of renal function. J Am Soc Nephrol 3:1163-1171, 1992
9. SCHUMER M, SAWCZUK I, GOBÉ G, O'TOOLE K, CONNOR J, OLSSON C, WISE G, BUTTYAN R: Morphological, biochemical and molecular evidence of apoptosis during reperfusion phase after brief periods of renal ischemia. Am J Pathol 140:831-838, 1992
10. SAUNDERS JR, AMINIAN A, MCCAE JL, O'FARRELL KA, ADAM WR, MURPHY BF: Clusterin depletion enhances immune glomerular injury in the isolated perfused kidney. Kidney Int 45:817-827, 1994
11. MURPHY BF, KIRZBAUM L, WALKER ID, D'APICE AJF: SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits of glomerulonephritis. J Clin Invest 81:1858-1864, 1988
12. MURPHY BF, DAVIES DJ, MORROW W, D'APICE AJF: Localization of terminal complement components, S-protein and SP-40,40 in renal biopsies. Pathology 21:275-278, 1989
13. EDDY AA, FRITZ IB: Localization of clusterin in the epimembranous deposits of passive Heymann nephritis. Kidney Int 39:247-252, 1991
14. FRENCH LE, TSCHOPP J, SCHIFFERLI JA: Clusterin in renal tissue: Preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli. Clin Exp Immunol 88:389-393, 1992
15. DVERGSTEN J, MANIVEL JC, CORREA-ROTTER R, ROSENBERG ME: Expression of clusterin in human renal diseases. Kidney Int 45:828-835, 1994
16. PARCZYK K, PILARSKY C, RACHEL U, KOCH-BRANDT C: Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomas. J Cancer Res CUn Oncol 120:186-188, 1994
17. RENNIE PS, BRUCHOVSKY N, BUTTYAN R, BENSON M, CHENG H: Gene expression during the early phases of regression of the androgen-dependent Shionogi mouse mammary carcinoma. Cancer Res 48:6309-6312, 1988
18. KYPRIANOU N, ENGLISH HF, ISAACS JT: Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 50:3748-3753, 1990
19. KYPRIANOU N, ENGLISH HF, DAVIDSON NE, ISAACS JT: Programmed cell death during regression of the MCF-7 human breast cancer following oestrogen ablation. Cancer Res 51:162-166, 1991
20. EGAWA S, KADMON D, MILLER GJ, SCARDINO PT, THOMPSON TC: Alterations in mRNA levels for growth-related genes after transplantation into castrated hosts in oncogene-induced clonal mouse prostate carcinoma. Molec Carcin 5:52-61, 1992
21. FRENCH LE, SAPPINO A-P, TSCHOPP J, SCHIFFERLI JA: Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus. J Clin Invest 90:1919-1925, 1992
22. KADOMATSU K, ANZANO MA, SLAYTER MV, WINOKUR TS, SMITH JM, SPORN MB: Expression of sulfated glycoprotein 2 is associated with carcinogenesis induced by N-nitroso-N-methylurea in rat prostate and seminal vesicle. Cancer Res 53:1480-1483, 1993
23. WEISSNER C, BACK T, BONNEKOH P, KOHNO K, GEHRMANN J, HOSSMAN K-A: Sulfated glycoprotein-2 mRNA in the rat brain following transient forebrain ischemia. Molec Brain Res 20:345-352, 1993
24. WILSON MR, ROETH PJ, EASTERBROOK-SMITH SB: Clusterin enhances the formation of insoluble immune complexes. Biochem Biophys Res Commun 28:985-990, 1991
25. O' BRYAN MK, BAKER HWG, SAUNDERS JR, KIRZBAUM L, WALKER ID, HUDSON P, LIU DY, GLEW MD, D'APICE AJF, MURPHY BF: Human seminal clusterin (sp-40,40). Isolation and characterization. J Clin Invest 85:1477-1486, 1990
26. TENNISWOOD MP, GUENETTE RS, LAKINS J, MOOIBROEK M, WONG P, WELSH J-E: Active cell death in hormone-dependent tissues. Cancer Metas Rev 11:197-220, 1992
27. FRITZ IB: What is clusterin? Clin Exp Immunol 88:375, 1992
28. FRITZ IB, MURPHY BF: Clusterin. Insights into a multifunctional protein. TEM 4:41-45, 1993
29. BANDYK G, SAWCZUK IS, OLSSON CA, KATZ AE, BUTTYAN R: Characterization of the products of a gene expressed during androgen-programmed cell death and their potential use as a marker of urogenital injury. J Urol 143:407-413, 1990
30. JENNE DE, TSCHOPP J: Clusterin: The intriguing guises of a widely expressed glycoprotein. TIBS 17:154-159, 1992
31. GARDEN GA, BOTHWELL M, RUBEL EW: Lack of correspondence between mRNA expression for a putative cell death molecule (SGP-2) and neuronal cell death in the central nervous system. J Neurobiol 22:590-604, 1991
32. FRENCH LE, WOHLWEND A, SAPPINO A-P, TSCHOPP J, SCHIFFERLI JA: Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J Clin Invest 93:877-884, 1994
33. GOBÉ GC, AXELSEN RA: Genesis of renal tubular atrophy in experimental hydronephrosis. Role of apoptosis. Lab Invest 56:273-281, 1987
34. NORMAN J, BOHMAN R, FISCHMANN G, BOWEN J, MCDONOUGH A, SLAMON D, FINE L: Patterns of mRNA expression during early cell growth differ in kidney epithelial cells destined to undergo compensatory hypertrophy versus regenerative hyperplasia. Proc Natl Acad Sci USA 85:6768-6772, 1988
35. SAWCZUK IS, OLSSON CA, BUTTAN R, NGUYEN-HUU MC, ZIMMERMAN KA, ALT FW, ZAKERI Z, WOLGEMUTH D, REITELMAN C: Gene expression in renal growth and regrowth. J Urol 140:1145-1148, 1988
36. GOBÉ GC, AXELSEN RA, SEARLE JW: Cellular events in experimental unilateral ischaemic renal atrophy, and in regeneration after contralateral nephrectomy. Lab Invest 63:770-779, 1990
37. THOMPSON CB, CHALLONER PB, NIEMAN PE, GROUDINE M: Expression of the c-myb proto-oncogene during cellular proliferation. Nature 319:374-380, 1986
38. BLANC P, ETIENNE H, DAUJAT M, FABRE I, ZINDY F, DOMERGUE J, ASTRE C, ST AUBERT B, MICHEL H, MAUREL P: Mitotic responsiveness of cultures of human hepatocytes to epidermal growth factor, transforming growth factor alpha, and human serum. Gastroenterology 102:1340-1350, 1992
39. WALKER NI, HARMON BV, GOBÉ GC, KERR JFR: Patterns of cell death. Meth Achiv Exp Pathol 13:18-54, 1988
40. GOBÉ GC, AXELSEN RA, HARMON BV, ALLAN DJ: Cell death by apoptosis following X-irradiation of the foetal and neonatal rat kidney. Int J Radiat Res 54:567-576, 1988
41. KERR JFR, GOBÉ GC, CUMMINGS MC, WINTERFORD C, HARMON BV: Apoptosis: Its empirical and conceptual basis, in Apoptosis, AIDS and Cancer, edited by MONTAGNIER L, GOURGEON M-L, TOMEI D, New York, Marcel Dekker Inc. (in press)
42. ANSARI B, COATES PJ, GREENSTEIN BD, HALL PA: In situ endlabelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 170:1-8, 1993
43. WYLLIE AH: Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview. Cancer Metas Rev 11:95-103, 1992
44. KERR J, WINTERFORD C, HARMON B: Apoptosis. Its significance in cancer and cancer therapy. Cancer 73:2013-2026, 1994